Indeed, MEK–ERK pathway inhibition in BRAFV600E-induced thyroid cancer mouse models partially restores the expression of thyroid-related genes and iodide uptake [92,97]. The gene discussed is MAP2K7; the disease is thyroid gland carcinoma.